|
EP1359915A1
|
|
Urotensin-ii receptor antagonists
|
|
GB0130547D0
|
|
Novel compounds
|
|
GB0130331D0
|
|
Compounds
|
|
GB0130352D0
|
|
Novel compounds
|
|
GB0130342D0
|
|
Compounds
|
|
GB0127145D0
|
|
Compounds
|
|
GB0127140D0
|
|
Novel compounds
|
|
GB0127143D0
|
|
Novel compounds
|
|
GB0127139D0
|
|
Novel compounds
|
|
EP1237851A2
|
|
SALTS OF i Cis /i -4-CYANO-4- 3-(CYCLOPENTYLOXY)-4-METHOXYPHENYL]CYCLOHEXANE-1-CARBOXYLIC ACID
|
|
EP1233768A1
|
|
Carvedilol methanesulfonate
|
|
EP1067466A2
|
|
Genome browser interface
|
|
GB0011802D0
|
|
Method for enhancing cognitive function
|
|
GC0000177A
|
|
Thrombopoietin mimetics
|
|
EP1114058A1
|
|
Polynucleotide and polypeptide sequences encoding rat mdr1a and screening methods thereof
|
|
EP1062242A1
|
|
Human g-protein coupled receptor (gpr25)
|
|
GB9902138D0
|
|
Container
|
|
GB9827425D0
|
|
Novel compounds
|
|
GB9821072D0
|
|
Medicaments
|
|
EP0926238A2
|
|
Putative Adrenomedullin receptor polypeptide
|
